BIO-TECHNE Corp Quarterly Operating Income (Loss) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIO-TECHNE Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q2 2024.
  • BIO-TECHNE Corp Operating Income (Loss) for the quarter ending June 30, 2024 was $45.8M, a 51.5% decline year-over-year.
  • BIO-TECHNE Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was $207M, a 30.9% decline year-over-year.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2024 was $207M, a 30.9% decline from 2023.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2023 was $299M, a 0.79% increase from 2022.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2022 was $297M, a 25% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $207M $45.8M -$48.7M -51.5% Apr 1, 2024 Jun 30, 2024 10-K 2024-08-22
Q1 2024 $255M $67M -$13.2M -16.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $269M $38M -$29.9M -44% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $298M $55.9M -$455K -0.81% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $299M $94.5M +$14M +17.3% Apr 1, 2023 Jun 30, 2023 10-K 2024-08-22
Q1 2023 $285M $80.2M -$10.2M -11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $295M $67.9M +$5.54M +8.89% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $290M $56.3M -$6.91M -10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $297M $80.6M +$12M +17.5% Apr 1, 2022 Jun 30, 2022 10-K 2024-08-22
Q1 2022 $285M $90.4M +$21.8M +31.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $263M $62.3M +$11.4M +22.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $251M $63.2M +$14.1M +28.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $237M $68.6M +$29.3M +74.5% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-23
Q1 2021 $208M $68.6M +$20.8M +43.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $187M $51M +$14M +37.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-07
Q3 2020 $173M $49.1M +$15.8M +47.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $157M $39.3M -$3.95M -9.14% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-24
Q1 2020 $161M $47.8M +$3.7M +8.39% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $158M $37M +$3.39M +10.1% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-08
Q3 2019 $154M $33.3M +$7.56M +29.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $147M $43.3M +$348K +0.81% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-25
Q1 2019 $146M $44.1M +$1.01M +2.34% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $145M $33.6M +$9.46M +39.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $136M $25.8M -$268K -1.03% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $136M $42.9M +$2.87M +7.17% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-26
Q1 2018 $133M $43.1M +$9.58M +28.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $124M $24.1M +$6.27M +35% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $117M $26M -$3.13M -10.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $121M $40M +$32K +0.08% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-11-06
Q1 2017 $121M $33.5M -$10M -23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $131M $17.9M -$18.1M -50.4% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $149M $29.2M -$1.87M -6.03% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $151M $40M +$2.21M +5.85% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-27
Q1 2016 $148M $43.5M +$4.1M +10.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $144M $36M +$1.45M +4.18% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $143M $31M -$4.19M -11.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $147M $37.8M -$1.05M -2.69% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-07
Q1 2015 $148M $39.4M -$6.34M -13.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $154M $34.6M -$1.16M -3.26% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $156M $35.2M -$4.18M -10.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $160M $38.8M +$157M Apr 1, 2014 Jun 30, 2014 10-K 2016-08-29
Q1 2014 $2.41M $45.8M +$1.82M +4.15% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $586K $35.7M -$1.16M -3.14% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $1.75M $39.4M +$1.59M +4.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $158K -$118M -$160M -387% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-31
Q1 2013 $160M $43.9M -$2.42M -5.21% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $162M $36.9M -$778K -2.07% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-04
Q3 2012 $163M $37.8M -$3.14M -7.68% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $166M $41.2M -$1.39M -3.25% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-29
Q1 2012 $168M $46.4M +$1.62M +3.63% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $166M $37.7M +$331K +0.89% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 $166M $40.9M +$2.58M +6.74% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $163M $42.6M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-29
Q1 2011 $44.7M +$3.09M +7.42% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $37.4M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-07
Q3 2010 $38.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q1 2010 $41.6M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.